Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
7
×
boston blog main
boston top stories
life sciences
national blog main
new york blog main
7
×
san diego blog main
7
×
national top stories
san francisco blog main
biotech
clinical trials
fda
new york top stories
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
drugs
hereditary transthyretin amyloidosis
indiana blog main
inotersen
patisiran
raleigh-durham blog main
san francisco top stories
seattle blog main
tafamidis
boston university
boulder/denver blog main
detroit blog main
drug delivery
medical devices
onpattro
pfizer
rna interference
software
startups
texas blog main
vc
venture capital
vyndaqel
wisconsin blog main
What
alnylam
drug
fda
medicine
ago
biotechs
device
ipo
ipos
life
make
medical
patients
rna
rnai
science
uses
way
afternoon
alnylam’s
approve
approved
approves
awaits
beta
better
biological
bionics
blood
boston’s
capital
cells
chose
city
close
closed
company
considering
crossed
data
Language
unset
Current search:
boston
×
" san diego blog main "
×
" new york blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision